Table of Contents Author Guidelines Submit a Manuscript
Journal of Analytical Methods in Chemistry
Volume 2012 (2012), Article ID 625979, 4 pages
http://dx.doi.org/10.1155/2012/625979
Research Article

RP-HPLC Method Development and Its Validation for Quantitative Determination of Rimonabant in Human Plasma

1Department of Pharmaceutical Chemistry, Rajiv Gandhi Prodhyugiki Mahavidhyalaya, Bhopal 462036, India
2Department of Pharmacognosy, R. C. Patel Institute of Pharmaceutical Education & Research, Shirpur 425405, India
3Department of Pharmaceutical Chemistry, Rajiv Gandhi Prodhyugiki Vishwavidhyalaya, Bhopal 462036, India
4Department of Pharmacognosy, Government College of Pharmacy, Osmanpura, Aurangabad 444604, India

Received 11 November 2011; Revised 10 January 2012; Accepted 7 February 2012

Academic Editor: R. Haeckel

Copyright © 2012 Shravan Bankey et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Bifulco, C. Grimaldi, P. Gazzerro, S. Pisanti, and A. Santoro, “Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects,” Molecular Pharmacology, vol. 71, no. 6, pp. 1445–1456, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Singh and S. Budhiraja, “Rimonabant: a new class of drug to fight obesity,” Indian Journal of Pharmacology, vol. 38, no. 3, pp. 220–221, 2006. View at Google Scholar · View at Scopus
  3. P. N. Patel and R. Pathak, “Rimonabant: a novel selective cannabinoid-1 receptor antagonist for of treatment obesity,” American Journal of Health-System Pharmacy, vol. 64, no. 5, pp. 481–489, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. http://www.sanofi-aventis.co.uk/products/Acomplia/SPC.pdf.
  5. R. Nirogi, V. Kandikere, K. Mudigonda, and D. Ajjala, “Liquid chromatography tandem mass spectrometry method for the quantification of rimonabant, a CB1 receptor antagonist, in human plasma,” Biomedical Chromatography, vol. 22, no. 5, pp. 469–477, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Hsieh, C. J. G. Duncan, and J. M. Brisson, “Fused-core silica column high-performance liquid chromatography/tandem mass spectrometric determination of rimonabant in mouse plasma,” Analytical Chemistry, vol. 79, no. 15, pp. 5668–5673, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. Resolution, RE No. 899, ANVISA, May 29, 2003.